VivoSeq
Other

Pregnancy

0

Pipeline Programs↗

90

Active Trials↗

33

Companies Involved↗

Pregnancy is an early-stage landscape with 0 programs across 33 companies. The most active players are GSK, Biogen, Pfizer.

Intelligence

Pipeline Metrics

Competitive Density

57/100

Pipeline Velocity

47/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

11/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

GSK logo

GSK

0 programs

PreclinicalBiogen logo

Biogen

0 programs

PreclinicalPfizer logo

Pfizer

0 programs

PreclinicalSanofi logo

Sanofi

0 programs

PreclinicalBristol-Myers Squibb logo

Bristol-Myers Squibb

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

500

clinical trials

Completed276 · 55%
Unknown status78 · 16%
Recruiting60 · 12%
Terminated37 · 7%
Withdrawn18 · 4%
Not yet recruiting16 · 3%
Other15 · 3%

Clinical Trials

Trial Activity

500 trials

The Clinical Features and Pregnancy Outcomes of CTD Patients
Recruiting·QQilu Hospital of Shandong University·N/A·NCT04918524·126 enrolled
UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study
Recruiting·UUniversity of North Carolina, Chapel Hill·Phase 4·NCT06158126·621 enrolled
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
Recruiting·OOhio State University·Phase 4·NCT06468202·10,742 enrolled
Effects of Vitamin D and Prebiotic Supplementation on Glucose Control During Pregnancy
Recruiting·HHuazhong University of Science and Technology·N/A·NCT06553729·500 enrolled
RSV Vaccine Pregnancy Registry
Recruiting·CCorEvitas·N/A·NCT06521944·2,062 enrolled
Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries
Recruiting·NNICHD Global Network for Women's and Children's Health·Phase 3·NCT06723392·1,134 enrolled
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
Recruiting·Argenx logoArgenx·N/A·NCT06299748·279 enrolled
Concurrent Versus Sequential Administration of Tdap and RSV Vaccines in Pregnancy
Recruiting·CCanadian Immunization Research Network·Phase 4·NCT07097012·60 enrolled
Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)
Recruiting·Sanofi logoSanofi·N/A·NCT04843111·50 enrolled
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)
Recruiting·Biogen logoBiogen·N/A·NCT05658497·908 enrolled
Assessing Interventions to Increase Tdap Acceptance for Non-birthing Partners in Pregnancy
Recruiting·WWomen and Infants Hospital of Rhode Island·Phase 4·NCT06135636·150 enrolled
Pregnancy Outcomes: Effects of Metformin Study (POEM Study)
Recruiting·—·Phase 3·NCT02947503·500 enrolled
the Effect of Hyaluronic Acid Intrauterine Wash on Endometrial Receptivity and Pregnancy Outcome
Recruiting·—·Phase 2·NCT06937645·120 enrolled
RCT Glargine vs NPH for Treatment of DM in Pregnancy
Recruiting·LLoyola University·Phase 3·NCT06619301·160 enrolled
Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics
Recruiting·—·Phase 4·NCT05757167·2,500 enrolled
Page 1 of 34

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)